Back to
JPMorgan Chase & Co.
ABBV
8 quarters
Position history for
JPMorgan Chase & Co.'s holdings in AbbVie Inc.
Yes. JPMorgan Chase holds 47,862,796 shares of ABBV (AbbVie), worth $12.2B, as of its Q2 2026 13F filing. It reduced the position by 8,878,895 shares (-15.7%) from Q1 2026. JPMorgan Chase has held ABBV in every 13F on record since Q3 2024, 8 quarterly filings. ABBV is 0.7% of JPMorgan Chase's reported 13F portfolio.
Current Value
$12.2B
Current Shares
47.9M
Total Value Change
+$1.8B
Total Shares Change
-4.4M
Quarter-by-Quarter History
Other major holders of ABBV: Vanguard Group Inc., BlackRock, Inc.